Bernstein Maintains Market Perform on Dyne Therapeutics, Raises Price Target to $24
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Bernstein analyst William Pickering maintains Dyne Therapeutics (NASDAQ:DYN) with a Market Perform and raises the price target from $23 to $24.
Bernstein analyst William Pickering maintains Dyne Therapeutics (NASDAQ:DYN) with a Market Perform and raises the price target from $23 to $24.